Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Anika Singanayagam et al.
Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.
LANCET INFECTIOUS DISEASES
(2022)
Article
Multidisciplinary Sciences
Delphine Planas et al.
Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.
Article
Immunology
Daphne F. M. Reukers et al.
Summary: This study in the Netherlands examined household transmission of SARS-CoV-2 and found higher infection secondary attack rates than previous studies. Children were shown to be less susceptible than adults.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Peter Nordstrom et al.
Summary: This retrospective cohort study investigated the effectiveness of COVID-19 vaccination in individuals who had previously been infected with SARS-CoV-2. The study found that natural immunity provided protection against SARS-CoV-2 infection and COVID-19 hospitalization for up to 20 months. Vaccination further reduced the risk of reinfection and hospitalization for up to 9 months, although the differences in absolute numbers, especially in hospitalizations, were small.
LANCET INFECTIOUS DISEASES
(2022)
Article
Multidisciplinary Sciences
Juliet R. C. Pulliam et al.
Summary: This study provides two methods for monitoring reinfection trends in routine surveillance data. The results suggest immune evasion by the Omicron variant in previously infected individuals in South Africa, and there has been an increase in the risk of having a third infection since mid-November 2021.
Review
Immunology
Hannah F. Fung et al.
Summary: The study found that the household secondary attack rate of SARS-CoV-2 was 17.1%, with potential underestimation if only single follow-up tests were conducted. Testing household contacts multiple times could increase the yield for identifying secondary cases, especially among older adult contacts and contacts of symptomatic cases.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Immunology
Nathaniel M. Lewis et al.
Summary: The study revealed a high secondary infection rate of COVID-19 within US households, with children and spouses/partners being the most affected groups. Individuals with immunocompromised conditions or household contacts with diabetes mellitus have a higher risk of infection.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Public, Environmental & Occupational Health
Komal Shah et al.
Summary: The secondary attack rate of COVID-19 in household contacts of pediatric index cases was found to be 1.7%, with family size being a key factor influencing the transmission.
JOURNAL OF PUBLIC HEALTH
(2021)
Article
Immunology
Anu Haveri et al.
Summary: According to a study, 89% of individuals infected with the WT SARS-CoV-2 strain still had neutralizing antibodies against the WT virus for at least 13 months, and 97% had S-IgG antibodies. On the other hand, only 36% of individuals still had N-IgG antibodies at 13 months. Patients with severe infections had higher antibody levels and are likely to remain seropositive for a longer period of time. Lower neutralizing antibody titers against variants compared to the WT virus, especially after a mild disease, suggest reduced protection against VOCs.
EUROPEAN JOURNAL OF IMMUNOLOGY
(2021)
Article
Multidisciplinary Sciences
Nicholas G. Davies et al.
Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.
Article
Microbiology
Mokhtar R. Gomaa et al.
Summary: The study in Egypt found a high household secondary attack rate of COVID-19, with most infections being asymptomatic or mild and resulting in a lasting neutralizing antibody response. Increasing public awareness about proper infection control within households may help reduce transmission in Egypt and similar areas.
Article
Virology
Stefan Gloeckner et al.
Summary: Humoral immunity plays a key role in mitigating the transmission of SARS-CoV-2 virus, with over 78% of individuals remaining seropositive for S-IgG antibodies even more than one year post-infection. Both homologous and heterologous vaccination regimens induce higher levels of neutralizing antibodies compared to mild infection, demonstrating the high effectiveness of available vaccines. Additionally, S-IgG levels can reliably predict neutralization capacity, making it a viable and cost-effective surrogate parameter.
Article
Virology
Indre Kucinskaite-Kodze et al.
Summary: The study found that detectable levels of SARS-CoV-2-specific antibodies persist up to 13 months after infection for the majority of the cases. After 6 months, 95% of previously infected individuals had virus-specific antibodies, with a third still showing IgM indicating persistence. 83% of recovered individuals were seropositive 13 months after the outbreak, with one case of confirmed asymptomatic reinfection.
Article
Microbiology
Chris Davis et al.
Summary: Vaccines have proven to be effective in controlling hospitalisation and deaths associated with SARS-CoV-2 infection, but the emergence of viral variants with novel antigenic profiles raises concerns. Serum from vaccine recipients showed reduced neutralisation against SARS-CoV-2 variants like B.1.617.1, B.1.617.2, and B.1.351. The BNT162b2 vaccine induced higher neutralising antibody titres compared to the ChAdOx1 vaccine, but both vaccines showed decreased efficacy against certain variants.
Article
Microbiology
Xiaodong Tian et al.
Summary: Individuals with natural asymptomatic SARS-CoV-2 infection show robust antibody responses lasting 6 to 12 months, with S-IgG being more stable than N-IgG. While antibody responses gradually decline over time, neutralization activity also decreases, with only a portion of individuals displaying potent neutralization activity after 12 months of infection.
FRONTIERS IN MICROBIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Markus Hoffmann et al.
Summary: The emerging SARS-CoV-2 variants may exhibit resistance to existing neutralizing antibodies and treatments, which could have significant implications for pandemic containment efforts.
Article
Infectious Diseases
Yumani Kuba et al.
Summary: The Okinawa prefecture in Japan confirmed 142 cases of coronavirus disease from February to May 2020, with 78 cases originating within a household with 174 household contacts. The secondary attack rates were higher for household members aged over 69 and those with underlying diseases, while isolation of the suspected patient immediately after symptom onset can help reduce secondary household infections.
JAPANESE JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Infectious Diseases
Lukas Galow et al.
JOURNAL OF INFECTION
(2021)
Article
Immunology
Lin Yao et al.
Summary: This study investigated the humoral and T and B cell responses in COVID-19 patients up to 343 days after infection. It found that most patients still had virus-specific immune memory responses approximately 1 year post-infection, which is promising for prevention from reinfection and vaccination strategies.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Microbiology
Anna Solastie et al.
Summary: This study presents an in-house FMIA serological assay for accurate detection of antibodies against SARS-CoV-2, which displayed higher specificity and sensitivity compared to other methods. Results indicate good correlation of antibody concentrations and comparability of different assays, highlighting the importance of reliable serological assays for estimating immunity persistence.
MICROBIOLOGY SPECTRUM
(2021)
Article
Biochemistry & Molecular Biology
David S. Khoury et al.
Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.
Article
Multidisciplinary Sciences
Zhongfang Wang et al.
Summary: The study found virus-specific T-cell memory in COVID-19 patients and close contacts. Patients had stronger T cell responses compared to close contacts. Despite lacking detectable infection, close contacts were able to gain T-cell immunity against SARS-CoV-2.
NATURE COMMUNICATIONS
(2021)
Article
Infectious Diseases
Olivier Bylicki et al.
Summary: Neutralizing antibody activity persists for up to 9 months following asymptomatic/mild COVID-19 among young adults, regardless of serological results.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Multidisciplinary Sciences
Terry C. Jones et al.
Summary: In a study of SARS-CoV-2 cases in Germany, it was found that younger subjects had lower viral loads but higher cell culture replication probabilities compared to older subjects. Additionally, 8% of subjects had viral loads above 10(9) copies per swab, with a third of them being presymptomatic, asymptomatic, or mildly symptomatic individuals with a mean age of 37.6 years. The B.1.1.7 lineage infections had a higher viral load and cell culture replication probability than non-B.1.1.7 subjects.
Article
Hematology
Clara Di Germanio et al.
Summary: The study found that antibody levels in COVID-19 convalescent plasma fluctuated over time, with direct detection methods showing increasing levels while indirect methods showed decreasing levels. Neutralization assays also showed declining responses, with different detection methods contributing to the variability in antibody stability over time.
Article
Immunology
Kristen A. Earle et al.
Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.
Article
Medicine, General & Internal
Kaihu Xiao et al.
Summary: Most COVID-19 survivors have detectable IgG antibodies for at least 12 months, with a significant decrease in the first 6 months. Lung lesions can be absorbed without sequelae in most patients, but a few severe cases may develop pulmonary fibrosis. About one-fifth of the patients experience cardiopulmonary dysfunction 6 months after discharge.
FRONTIERS IN MEDICINE
(2021)
Review
Medicine, General & Internal
Zachary J. Madewell et al.
Summary: This study conducted a systematic review and meta-analysis on the transmission of SARS-CoV-2 in households. By combining previous studies with new data, it found a household secondary attack rate of 18.9%. The study also analyzed characteristics of contacts and variants, showing higher SAR in contacts with comorbidities and for the B.1.1.7 variant.
Article
Medicine, General & Internal
Eric H. Y. Lau et al.
Summary: The study reveals that neutralizing antibodies produced after infection with the new coronavirus can still be detected for a considerable time after symptom onset, providing long-lasting protection against reinfection. The duration of this protection may be influenced by virus variants, with antibodies waning faster in children.
Article
Immunology
Lyle R. Petersen et al.
Summary: A study found that approximately 1 in 16 individuals previously infected with SARS-CoV-2 lacked IgG antibodies. The absence of antibodies was influenced by illness severity, race/ethnicity, obesity, and immunosuppressive drug therapy, and the seronegative proportion remained relatively stable within 90 days post symptom onset.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Pyoeng Gyun Choe et al.
Summary: Despite declining immunity, SARS-CoV-2 antibodies can still be detected up to one year after infection, even in mild COVID-19 patients, as shown in this study.
JOURNAL OF KOREAN MEDICAL SCIENCE
(2021)
Article
Health Care Sciences & Services
Kanika Kuwelker et al.
Summary: This study found that seropositivity provides more accurate household attack rates than RT-PCR, and children are equally susceptible to infection as young adults in households. Having fever or dyspnoea symptoms in index patients increased the risk of household transmission.
LANCET REGIONAL HEALTH-EUROPE
(2021)
Article
Public, Environmental & Occupational Health
Yolanda Angulo-Bazan et al.
Summary: This study described the transmission characteristics of SARS-CoV-2 among household members in low and high burden districts in Lima, Peru. Secondary cases were found in 40% of households, with a secondary attack rate of 53% among household members. 77.6% of cases were symptomatic.
CADERNOS DE SAUDE PUBLICA
(2021)
Article
Virology
Chuanmiao Liu et al.
Summary: The study revealed that IgG antibody levels remained stable in convalescent patients while IgM antibody levels decreased in early convalescence and were only detected in a few patients after six months, with higher IgG levels observed in severe and critical groups compared to moderate cases. Further investigation is needed to determine if these specific antibodies provide long-term protection in recovered COVID-19 patients.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Immunology
Sina Schwarzkopf et al.
Summary: The study found that in convalescent patients, immunity against SARS-CoV-2 may be mediated through T cells even in the absence of detectable IgG antibodies.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Virology
Craig Fenwick et al.
Summary: In this study, antibody responses to SARS-CoV-2 were evaluated in acute and postinfection subjects. The results show that responses against viral S and N proteins were equally sensitive in acute phase, but N responses decreased in postinfection phase while S responses persisted. The most sensitive assay used the native S protein trimer, suggesting its importance in estimating SARS-CoV-2 infections and assessing vaccine-induced responses.
JOURNAL OF VIROLOGY
(2021)
Article
Infectious Diseases
Victor M. Corman et al.
Article
Infectious Diseases
Anu Haveri et al.
Article
Medicine, General & Internal
Samira Fafi-Kremer et al.
Letter
Infectious Diseases
Hao Lei et al.
JOURNAL OF INFECTION
(2020)
Review
Medicine, General & Internal
Zachary J. Madewell et al.
Letter
Medicine, General & Internal
Johan Giesecke
